Publications | Resources

Browse a collection of academic publications and research papers, contributed to by personnel from the Unit.

Title

Author

Year

Critical Clade 1b Mpox in Adults with HIV in Uganda: A Case Series of Mucocutaneous Viral Dominance, Multidrug Resistant Superinfection, and Inflammatory Severity Markers.

Kaweesa, RE; Odoch, G; Nairuba, B; Ejou, P; Katende, JS; Semawule, S; Ntabadde, AD; Ankunda, V; Avumegah, MS; Nsubuga, JB; Kiyonga, E; Nsereko, C; Kaleebu, P; SERWANGA, J;

2026

VeriXiv (2026). 10.12688/verixiv.2604.1.

Metadata supporting "Understanding the role of gut microbiome in the relationship between environment, S. mansoni infection and Cardiovascular risk".

Walusimbi, B; ELLIOTT, A; WEBB, E;

2026

, London School of Hygiene & Tropical Medicine (London, United Kingdom) (2026). 10.17037/DATA.00004919.

Longitudinal assessment of changes in hair cortisol levels and associations with violence, poor mental health and harmful substance use among female sex workers in Nairobi, Kenya.

Panneh, M; Beattie, T; Ding, Q; Kabuti, R; Maisha Fiti study champions,; Ngurukiri, P; Kungu, M; ABRAMSKY, T; Pollock, J; Beksinska, A; Irungu, E; SEELEY, J; WEISS, HA; Elzagallaai, AA; Rieder, MJ; Kaul, R; Kimani, J; GAFOS, M; BRADLEY, J;

2026

PLOS global public health, (2026).6 1 10.1371/journal.pgph.0005013.

Prevalence and Determinants of Depression Among Adolescent Girls and Young Women at Risk of HIV in Urban Slums of Kampala.

Amanyire, P; Kinyanda, E; Kyohangirwe, L; Mpango, RS; Ssembajjwe, W; MAYANJA, Y;

2026

Inquiry : a journal of medical care organization, provision and financing, (2026).63, 10.1177/00469580251412738.

Eligibility for hepatitis B virus (HBV) treatment and prevalence of drug resistance in a Ugandan population cohort.

Lumley, SF; Kimono, B; Mugisha, J; Makanga, R; Mbonye, MK; Ojambo, K; Waddilove, E; Kent, C; Ssengendo, B; Ndungutse, R; McNaughton, AL; Muzaale, FN; SEELEY, J; Quick, J; Ocama, P; NEWTON, R; Matthews, PC;

2026

The Journal of infection, (2026).92 2 10.1016/j.jinf.2026.106682.

Trial design and enrolment characteristics of LATA (Long-Acting Treatment in Adolescents): A randomised, open-label, non-inferiority, 96-week trial evaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting i...

Anena, D; Chappell, E; Nazzinda, R; Kiilu, C; Chitsamatanga, M; Arumugam, T; Green, A; Kityo Mutuluuza, C; Bwakura-Dangarembizi, M; Siika, A; Archary, M; Jafta, L; Namukwaya, S; SEELEY, J; Akabwai, G; Mugerwa, H; Bevers, L; Burger, D; Walker, S; Bamford, A; South, A; Apoto, N; Bush, M; Thomason, MJ; Spittle, B; ... LATA Trial Team,

2026

Contemporary clinical trials, (2026).162, 10.1016/j.cct.2025.108213.

Individual and population-level risk factors for new HIV infections among adults in Eastern and Southern Africa.

SLAYMAKER, E; Calvert, C; MARSTON, M; RISHER, K; Imai-Eaton, JW; Moorhouse, L; PRICE, A; Abdul, R; Dube, A; Nabukalu, D; Obor, D; McLean, E; TLHAJOANE, M; Tomlin, K; Urassa, M; BAISLEY, K; CRAMPIN, A; Geubbels, E; Gregson, S; Herbst, K; Kwaro, D; Lutalo, T; Newton, R; TODD, J; ALPHA Network,;

2026

Nature communications, (2026).17 1 10.1038/s41467-025-67966-0.

Effect of BCG&amp;nbsp;Vaccination on Trained Immunity in Hiv-exposed Infants: A Randomised Controlled Study.

Namakula, R; COSE, S; Nankabirwa, V; Namugga, O; Netea, MG; Steinsland, H; Sommerfelt, H; Hanevik, K;

2026

Elsevier BV (2026). 10.2139/ssrn.6831527.

Critical Clade Ib Mpox in Adults with HIV in Uganda: A Prospective Observational Study of Viral Burden, Lesion Microbiology, and Inflammatory Markers.

Kaweesa, RE; Odoch, G; SERWANGA, J; PDF, S;

2026

Elsevier BV (2026). 10.2139/ssrn.6505063.

Maternal iron status and total immunoglobulin-G influence transplacental antibody transfer across eight diverse geographical settings.

Tiley, KS; Ten Hulscher-van Overbeek, H; Armitage, AE; Van Binnendijk, R; Holder, B; CLARKE, E; COSE, S; Dang, DA; Hoang, HT T; KAMPMANN, B; Van der Klis, F; Kazi, AM; Leuridan, E; Maertens, K; Maldonado, H; Omer, S; Pasetti, MF; Rots, N; Tapia, M; Wanlapakorn, N; Voysey, M;

2025

Vaccine, (2025).73, 10.1016/j.vaccine.2025.128132.